Concepedia

Marco Jansen

MJ

Statistics

Publications

5

Citations

303

H-Index

5

Active since

2002

Affiliations

University Medical Center Utrecht(Current)

Center for Translational Molecular Medicine

Princess Máxima Center

Genmab (Netherlands)

Marco Jansen is an author at University Medical Center Utrecht specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2002–2023

5

Publications

5

The High-Affinity IgG Receptor, FcγRI, Plays a Central Role in Antibody Therapy of Experimental Melanoma

Lisette Bevaart, Marco Jansen, Martine J. van Vugt et al. · Cancer Research · 2006 · 94 citations

, , +21

CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.

Heidi H. van Ojik, Lisette Bevaart, Christopher E. Dahle et al. · PubMed · 2003 · 93 citations

, , +15

Mac-1 (CD11b/CD18) is crucial for effective Fc receptor–mediated immunity to melanoma

Annemiek B. van Spriel, Heidi H. van Ojik, Annie Bakker et al. · Blood · 2002 · 71 citations · Full text

Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma

Mitchell Evers, Marjolein C. Stip, Kaylee M. Keller et al. · Journal for ImmunoTherapy of Cancer · 2021 · 26 citations · Full text

IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models

Marjolein C. Stip, Mitchell Evers, Maaike Nederend et al. · Journal for ImmunoTherapy of Cancer · 2023 · 19 citations · Full text

Rows per page

1–5 of 5